Pfizer Sued for $1M by Test Subject
An Oregon woman who developed osteonecrosis in both hips during a drug study of Tanezumab has filed suit against Pfizer Inc. claiming the company cancelled the study due to the risk of osteonecrosis with the drug – but failed to inform her. Plaintiff Candace Stewart alleges that she suffered osteonecrosis or bone death in her hips after agreeing to be a test